Related Experiment Videos
Structure-based subsite specificity mapping of human cathepsin D using statine-based inhibitors
P Majer1, J R Collins, S V Gulnik
1Structural Biochemistry Program, SAIC Frederick, National Cancer Institute-Frederick Cancer Research and Development Center, Maryland 21702-1201, USA. majer@ncifcrf.gov
Summary
Researchers designed novel statine-containing inhibitors to understand human cathepsin D
Area of Science:
- Biochemistry
- Enzymology
- Drug Discovery
Background:
- Human cathepsin D is a lysosomal aspartic protease.
- It is implicated in breast cancer metastasis and Alzheimer's disease.
Purpose of the Study:
- To design, synthesize, and test statine-containing inhibitors for human cathepsin D.
- To map cathepsin D subsite preferences using systematic modifications.
Main Methods:
- Crystal structure analysis of a human cathepsin D-pepstatin A complex.
- In vitro testing of synthesized statine-containing inhibitors.
- Structure-activity relationship (SAR) analysis and molecular modeling.
Main Results:
- Systematic modifications revealed specific subsite preferences for inhibitors.
- Observed side-chain preferences differed from those of peptide substrates.
- Nonadditive effects of single side-chain modifications were noted.
Conclusions:
- Entropy plays a significant stabilizing role in inhibitor binding to cathepsin D.
- Understanding these relationships aids in developing targeted cathepsin D inhibitors.